89 related articles for article (PubMed ID: 38635745)
1. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice.
Vázquez-Carrillo DI; Ocampo-Ruiz AL; Báez-Meza A; Ramírez-Hernández G; Adán-Castro E; García-Rodrigo JF; Dena-Beltrán JL; de Los Ríos EA; Sánchez-Martínez MK; Ortiz MG; Martínez de la Escalera G; Clapp C; Macotela Y
PLoS One; 2024; 19(4):e0301496. PubMed ID: 38635745
[TBL] [Abstract][Full Text] [Related]
3. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans.
Ponce AJ; Galván-Salas T; Lerma-Alvarado RM; Ruiz-Herrera X; Hernández-Cortés T; Valencia-Jiménez R; Cárdenas-Rodríguez LE; Martínez de la Escalera G; Clapp C; Macotela Y
Endocrine; 2020 Feb; 67(2):331-343. PubMed ID: 31919769
[TBL] [Abstract][Full Text] [Related]
4. Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males.
Ruiz-Herrera X; de Los Ríos EA; Díaz JM; Lerma-Alvarado RM; Martínez de la Escalera L; López-Barrera F; Lemini M; Arnold E; Martínez de la Escalera G; Clapp C; Macotela Y
Endocrinology; 2017 Jan; 158(1):56-68. PubMed ID: 27805870
[TBL] [Abstract][Full Text] [Related]
5. Ascorbic acid reduces insulin resistance and pancreatic steatosis by regulating adipocyte hypertrophy in obese ovariectomized mice.
Jeon S; Lee J; Shin Y; Yoon M
Can J Physiol Pharmacol; 2023 Jun; 101(6):294-303. PubMed ID: 36999637
[TBL] [Abstract][Full Text] [Related]
6. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
Tavares G; Marques D; Barra C; Rosendo-Silva D; Costa A; Rodrigues T; Gasparini P; Melo BF; Sacramento JF; Seiça R; Conde SV; Matafome P
Mol Metab; 2021 Sep; 51():101241. PubMed ID: 33933677
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia and insulin resistance.
Gierach M; Bruska-Sikorska M; Rojek M; Junik R
Endokrynol Pol; 2022; 73(6):959-967. PubMed ID: 36621922
[TBL] [Abstract][Full Text] [Related]
9. The beneficial metabolic actions of prolactin.
Macotela Y; Ruiz-Herrera X; Vázquez-Carrillo DI; Ramírez-Hernandez G; Martínez de la Escalera G; Clapp C
Front Endocrinol (Lausanne); 2022; 13():1001703. PubMed ID: 36213259
[TBL] [Abstract][Full Text] [Related]
10. Severe Hyperprolactinemia Promotes Brown Adipose Tissue Whitening and Aggravates High Fat Diet Induced Metabolic Imbalance.
Lopez-Vicchi F; De Winne C; Ornstein AM; Sorianello E; Toneatto J; Becu-Villalobos D
Front Endocrinol (Lausanne); 2022; 13():883092. PubMed ID: 35757410
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus.
Kabir MT; Ferdous Mitu J; Akter R; Akhtar MF; Saleem A; Al-Harrasi A; Bhatia S; Rahman MS; Damiri F; Berrada M; Rahman MH
Environ Sci Pollut Res Int; 2022 Jul; 29(31):46385-46404. PubMed ID: 35486279
[TBL] [Abstract][Full Text] [Related]
12. Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats.
Adán-Castro E; Siqueiros-Márquez L; Ramírez-Hernández G; Díaz-Lezama N; Ruíz-Herrera X; Núñez FF; Núñez-Amaro CD; Robles-Osorio ML; Bertsch T; Triebel J; Martínez de la Escalera G; Clapp C
J Neuroendocrinol; 2022 Apr; 34(4):e13091. PubMed ID: 35078262
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-Induced Adaptation in Glucose Homeostasis in Mouse Pregnancy Is Mediated by the Pancreas and Not in the Forebrain.
Khant Aung Z; Kokay IC; Grattan DR; Ladyman SR
Front Endocrinol (Lausanne); 2021; 12():765976. PubMed ID: 34867810
[TBL] [Abstract][Full Text] [Related]
14. Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function.
Tavares G; Martins FO; Melo BF; Matafome P; Conde SV
Front Pharmacol; 2021; 12():713418. PubMed ID: 34566639
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
